Footnotes
This manuscript has recently been accepted for publication in the ERJ Open Research. It is published here in its accepted form prior to copyediting and typesetting by our production team. After these production processes are complete and the authors have approved the resulting proofs, the article will move to the latest issue of the ERJOR online. Please open or download the PDF to view this article.
Conflict of interest: Dr. Munoz reports personal fees from AstraZeneca, personal fees from Boehringer Ingelheim, grants and personal fees from GlaxoSmithkline, grants from Menarini, personal fees from Novartis, personal fees from Teva, personal fees from Mundifarma, grants and personal fees from Chiesi, personal fees from Faes, outside the submitted work.
Conflict of interest: Dr. Pilia has nothing to disclose.
Conflict of interest: Dr. Ojanguren reports personal fees from GSK, personal fees from Astrazeneca, personal fees from Novatirs, personal fees from Boeheringuer_ingelheim, personal fees from Bial, personal fees from MSD, personal fees from Esteve, personal fees from Chiesi, grants and personal fees from Mundipharma, personal fees from TEVA, outside the submitted work.
Conflict of interest: Dr. Romero-Mesones has nothing to disclose.
Conflict of interest: Dr. Cruz has nothing to disclose.
This is a PDF-only article. Please click on the PDF link above to read it.
- Received April 25, 2020.
- Accepted October 27, 2020.
- Copyright ©ERS 2020
This article is open access and distributed under the terms of the Creative Commons Attribution Non-Commercial Licence 4.0.
